India's Pharma Industry Eyes Global Recognition

New Delhi- The Union Health Minister JP Nadda stated that the country's pharmaceutical industry can only achieve global recognition if a world-class regulatory framework is created.

In this regard, he has directed the officials of the Central Drugs Standard Control Organization (CDSCO) to prepare a roadmap for the development of the CDSCO's regulatory system in a timely manner so that it can match the global standards.

The Union Health Minister reviewed the Drugs, Cosmetics and Medical Devices Regulations. During this review, he emphasized the need for transparency in the working of CDSCO.

He said that the quality of drugs manufactured and sold in India should meet the highest standards of global quality standards. " Our government is dedicated to supporting and strengthening the capacity and quality of products in the MSME sector for drug manufacturing, while also encouraging compliance with regulatory requirements" he said.

Nadda said that the upscaling of the pharmaceutical industry needs to be system-based and focus on the highest standards of uniformity, technical upgradation, and futuristic approaches. He said that for the export of drugs and pharmaceuticals, a system should be designed for proper intervention to maintain the quality of drugs being exported.

He said that CDSCO should be in continuous dialogue with the pharmaceutical industry. He said that both the regulator and the industry should work together with the highest principles of transparency to ensure the products manufactured and sold by India meet the highest indices of global quality standards.